Monoclonal Antibodies (IgMs) are antibodies that are made by identical immune cells, cloned from a single parent cell. They are therefore of constant structure and bind to the same foreign markers (called “antigens”). The technology behind the generation of monoclonal antibodies was discovered in 1972 by César Milstein and Georges Köhler – scientists at the Roche-funded Basel Institute for Immunology – who were later to win the Nobel Prize. Monoclonal antibodies revolutionized biological research and built the basis for the use of therapeutic antibodies in medicine and for the entire biotechnology industry.

Due to the COVID-19 pandemic, the global Monoclonal Mouse Antibody market size is estimated to be worth US$ 8986.6 million in 2021 and is forecast to a readjusted size of US$ 12110 million by 2028 with a CAGR of 4.3% during the forecast period 2022-2028. Fully considering the economic change by this health crisis, the Europe Monoclonal Mouse Antibody market is estimated at US$ million in 2022, while the United States and China are forecast to reach US$ million and US$ million by 2028, respectively. The proportion of the United States is % in 2022, while Chinese percentage is %, and it is predicted that China market share will reach % in 2028, trailing a CAGR of % through the analysis period. As for the Europe Monoclonal Mouse Antibody landscape, Germany is projected to reach US$ million by 2028. and in Asia, the notable markets are Japan and South Korea, CAGR is % and % respectively for the next 6-year period.

The key players are Roche, Johnson & Johnson, Merck, Novartis, AbbVie, Amgen, Pfizer, Bayer, Lilly, Bristol-Myers Squibb, GlaxoSmithKline, Biogen, AstraZeneca, Sanofi, Alexion Pharmaceuticals and Seattle Genetics, etc, with about 57% market shares.

This report focuses on Monoclonal Mouse Antibody volume and value at the global level, regional level, and company level. From a global perspective, this report represents overall Monoclonal Mouse Antibody market size by analysing historical data and future prospect. Regionally, this report focuses on several key regions: North America, Europe, Japan, China and India, etc.

Global Monoclonal Mouse Antibody Market: Segment Analysis

The research report includes specific segments by region (country), by company, by Type and by Application. This study provides information about the sales and revenue during the historic and forecasted period of 2017 to 2028. Understanding the segments helps in identifying the importance of different factors that aid the market growth.


Segment by Type


IgM

IgG

IgA

Others


Segment by Application


Therapeutic

Research

Diagnostic

ELISA kits

By Region

North America

U.S.

Canada

Europe

Germany

France

U.K.

Italy

Russia

Asia-Pacific

China

Japan

South Korea

India

Australia

Taiwan

Indonesia

Thailand

Malaysia

Philippines

Vietnam

Latin America

Mexico

Brazil

Argentina

Middle East & Africa

Turkey

Saudi Arabia

U.A.E


By Company


Roche

Johnson & Johnson

Merck

Novartis

AbbVie

Amgen

Pfizer

Bayer

Lilly

Bristol-Myers Squibb

GlaxoSmithKline

Biogen

AstraZeneca

Sanofi

Alexion Pharmaceuticals

Seattle Genetics